The prognostic role of next-generation imaging-driven upstaging in newly diagnosed prostate cancer patients.

MLA

Bauckneht, Matteo, et al. “The Prognostic Role of Next-Generation Imaging-Driven Upstaging in Newly Diagnosed Prostate Cancer Patients.” European Journal of Nuclear Medicine and Molecular Imaging, vol. 51, no. 3, Feb. 2024, pp. 864–70. EBSCOhost, https://doi.org/10.1007/s00259-023-06490-z.

APA

Bauckneht, M., Checcucci, E., Cisero, E., Rizzo, A., Racca, M., De Cillis, S., Amparore, D., De Luca, S., Fiori, C., Rescigno, P., & Porpiglia, F. (2024). The prognostic role of next-generation imaging-driven upstaging in newly diagnosed prostate cancer patients. European Journal of Nuclear Medicine and Molecular Imaging, 51(3), 864–870. https://doi.org/10.1007/s00259-023-06490-z

Chicago

Bauckneht, Matteo, Enrico Checcucci, Edoardo Cisero, Alessio Rizzo, Manuela Racca, Sabrina De Cillis, Daniele Amparore, et al. 2024. “The Prognostic Role of Next-Generation Imaging-Driven Upstaging in Newly Diagnosed Prostate Cancer Patients.” European Journal of Nuclear Medicine and Molecular Imaging 51 (3): 864–70. doi:10.1007/s00259-023-06490-z.